Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT03900221
Recruiting Observational

French Registry for Monitoring Pregnancies for Multiple Sclerosis

NCT03900221 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2019-08-12
Last updated
2026-01-05

Condition(s) studied

Sclerosis, MultipleNeuromyelitis Optica Spectrum DisorderMyelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related DisordersPregnancy Abnormal

Investigational drug(s) / intervention(s)

No intervention

No intervention: No intervention

Study summary

The influence of pregnancy on the course of multiple sclerosis (MS) has long been a controversial topic. After the publication of the first large prospective study of pregnancy and MS in 1998, counselling of women with MS has radically changed and many patients have been able to fulfill their desire of motherhood. However, there are still some challenges for the neurologist, who has to face old unanswered questions or new issues, regarding the use of disease modifying drugs (DMDs) in this period of life, effects on the short and long term outcome of the mother (in terms of relapses and disability) and the child, role of breast-feeding and locoregional analgesia.

To set up a national prospective pregnancy registry for patients with MS, nested within the Observatoire Français de la Sclérose en Plaque (OFSEP) cohort, owing to a better knowledge of interactions between MS and pregnancy-related issues (pregnancy itself, locoregional analgesia, breastfeeding, impact of using or stopping DMDs on women/children…)

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All groups of patients eligible to participate to the Observatoire Français de la Sclérose en Plaque (OFSEP), including : * Definite Multiple sclerosis (MS) according to McDonald criteria * Whatever the clinical course (single attack MS, relapsing-remitting MS, secondary progressive MS, primary progressive MS) * Radiologically Isolated Syndromes (RIS) (will be validated by the RIS expert group) * Clinically Isolated Syndromes (CIS) * Neuromyelitis optica (NMO) and NMO spectrum disorders (will be validated by the "Neuro-optico-myélite aiguë de Devic et des syndromes neurologiques apparentés" (NOMADMUS) expert group) * No age limit (patients under the age of 18 might be included, provided informed consent is obtained from the parents) * Ongoing pregnancy: there will be no limit in the gestational age at inclusion. Women can be included at any time before delivery, but the gestational age at inclusion will be recorded and introduced in the analyses whenever pertinent. However, neurologists and patients will be encouraged to start the study as soon as pregnancy is diagnosed. * Able to give informed consent * Able to read and/or understand French Exclusion Criteria: * None

Primary outcome measure(s)

Trial sites (48)

FacilityCityRegionStatus
Chu D'Amiens Amiens France Recruiting
Centre Hospitalier Annecy Genevois Annecy France Recruiting
Centre Hospitalier d'Avignon Avignon France Recruiting
Hopital Jean Minjoz Besançon France Recruiting
Hopital Pellegrin Bordeaux France Recruiting
Hôpital de Brive Brive-la-Gaillarde France Recruiting
Hôpital Neurologique Pierre Wertheimer Bron France Recruiting
Hopital Cote de Nacre Caen France Recruiting
Centre hospitalier Métropole Savoie Chambéry France Recruiting
Hopital Gabriel Montpied Clermont-Ferrand France Recruiting
Hopital Henri Mondor Créteil France Recruiting
Hopital Du Bocage Dijon France Recruiting
Ch Epinal Épinal France Recruiting
Hôpital Raymond Poincaré Garches France Recruiting
Centre hospitalier Joséphine Baker Gonesse Gonesse France Recruiting
Chu de Grenoble Grenoble France Recruiting
Centre Hospitalier de Versailles Hôpital Andre Mignot Le Chesnay France Recruiting
Hôpital St Vincent De Paul Lille France Recruiting
Chru de Lille Lille France Recruiting
Hopital Dupuytren Limoges France Recruiting
Cabinet médical Dr Philippe NEUSCHWANDER Lyon France Recruiting
Centre Hospitalier Saint Joseph Saint Luc Lyon France Recruiting
Cabinet médical Dr C. CORNUT-CHAUVINC Lyon France Recruiting
Hopital Timone Adultes Marseille France Recruiting
Hopital Gui de Chauliac Montpellier France Recruiting
Cabinet médical Dr L. GUILLOTON Mornant France Recruiting
Hôpital Central Nancy France Recruiting
Hopital Pasteur Nice France Recruiting
Hopital Caremeau Nîmes France Recruiting
Hôpital Paris Saint Joseph Paris France Recruiting
Fondation Rotschild Paris France Recruiting
Hôpital national des Quinze-Vingt. Paris France Recruiting
Hopital Pitie Salpetriere Paris France Recruiting
Chi Poissy Saint Germain En Laye Poissy France Recruiting
Chr La Miletrie Poitiers France Recruiting
Hopital Rene Dubos Pontoise France Recruiting
Hopital Pontchaillou Rennes France Recruiting
Hôpital Charles-Nicolle Rouen France Recruiting
Centre Hospitalier de Saint-Denis Saint-Denis France Recruiting
Hopital G. Et R. Laennec Saint-Herblain France Recruiting

+ 8 more sites — see the full list on the official registry below.

More Hospices Civils de Lyon trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03900221 on ClinicalTrials.gov ↗ ← All trials in France